Intel will cut 15,000 positions after an 85% profit drop in Q2. It is trailing AMD and Nvidia in AI chip sales. Increased investments in next-gen chips and facilities have strained its financials, but the company aims for future growth.
Intel to Cut Workforce by 15,000 After Q2 Profit Plunges 85%, Trailing AMD's AI Chip Success
Intel announced on August 1 that it intends to eliminate 15,000 positions following an 85% year-over-year decrease in second-quarter profits. According to Nikkei Asia, this announcement occurred two days after AMD's impressive earnings, bolstered by robust AI chip sales, were disclosed.
Intel has strategically increased its expenditures on developing next-generation chips and constructing its fabrication facilities in response to the intensifying competition from AMD and Nvidia in the competitive market for chips that power artificial intelligence. This strategic move has resulted in a decline in its financial performance, but it positions the company for future growth.
Intel's revenue for the three months ending June 29 was $12.8 billion, a 1% decrease from the previous year. Net income decreased by 85% to $83 million.
In contrast, AMD disclosed on July 30 that its revenue increased by 9% to $5.8 billion. The driving force behind this success was the strong AI data center processor sales, which led to a 19% increase in net income to $1.1 billion, showcasing the company's strength in this market.
In extended trading on August 1, Intel shares were down 20% from the day's closing price. AMD and Nvidia experienced a modest increase in value.
Intel to Cut 15,000 Jobs and Implement $10 Billion Cost Savings Plan to Boost Efficiency Amid Struggles in AI Market
In a news release, Intel CEO Pat Gelsinger said, "Our Q2 financial performance was disappointing, even as we hit key product and process technology milestones." Chief Financial Officer David Zinsner blamed the weak quarter on "the accelerated ramp of our AI PC product, higher than typical charges related to non-core businesses, and the impact from unused capacity."
AMD and Intel have been vying for the second position and placing bets on AI-enabled PCs as Nvidia continues to expand its lead in AI processors. However, AMD's sales have experienced significantly more robust growth in recent quarters.
In 2025, Intel intends to “increase efficiency and market competitiveness” by implementing a $10 billion cost savings plan that includes a 15% reduction in its workforce, or approximately 15,000 employees. This bold move demonstrates the company's commitment to improving its financial performance and market competitiveness.
"Our revenues have not grown as expected -- and we've yet to fully benefit from powerful trends, like AI," Gelsigner explained in a note to employees on August 1.
"Our costs are too high, our margins are too low," he continued. "We need bolder actions to address both -- particularly given our financial results and outlook for the second half of 2024, which is tougher than previously expected."


Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



